Clinical trial
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary…
NCT00201422 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00201422 |
|---|---|
| Title | Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma |
| Official title | Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type of The Stomach |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | MALT Lymphoma |
| Intervention type | Other |
| Interventions | Omeprazole, Amoxicillin, Clarithromycin |
| Enrollment | 70 |
| Start date | Jun 1, 1996 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 28, 2016 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: